GlobeNewswire by notified

ForFarmers N.V.: Resolutions Annual General Meeting of Shareholders ForFarmers N.V.


Lochem, 14 April 2022

Resolutions Annual General Meeting of Shareholders ForFarmers N.V.

During the Annual General Meeting of Shareholders of ForFarmers N.V. (hereafter: the ‘General Meeting’ and ‘ForFarmers’ respectively), which was held today, the shareholders adopted the ForFarmers annual accounts over the 2021 financial year and approved the dividend proposal for the same financial year. 

Dividend of €0.29 per ordinary share (€0.19 dividend and €0.10 special dividend) will be paid entirely in cash to the shareholders of ForFarmers, after deducting 15% dividend tax. The ex-dividend date is 20 April 2022 and payment will take place on 28 April 2022.

Other resolutions

  • An advisory vote was cast in favour of the 2021 remuneration report (95.1% in favour; 4.9% against).
  • All members of the Executive Board have been discharged from performing their duties during the financial year 2021.
  • All members of the Supervisory Board have been discharged from performing their duties during the financial year 2021.
  • KPMG Accountants N.V. has been appointed as auditor of ForFarmers for auditing the 2022 financial statements and executive board report.
  • The remuneration policy for the Executive Board and the Supervisory Board has been adopted, effective as of the financial year 2022.
  • Mr P.E. Wolleswinkel (COO ForFarmers Netherlands/Belgium) has been appointed as member of the Executive Board.
  • Mrs M. Folkers – in ‘t Hout has been appointed as member of the Supervisory Board.
  • Mr R.H.A. Gerritzen and Mr V.A.M. Hulshof have been reappointed as members of the Supervisory Board.
  • The Executive Board has been designated as the authorized body, upon approval of the Supervisory Board, to issue ordinary shares and grant rights to subscribe for ordinary shares with a limitation up to 10% of the issued ordinary shares for the duration of 18 months.
  • The Executive Board has been designated as the authorized body, upon approval of the Supervisory Board, to restrict or exclude the pre-emptive right of shareholders for the duration of 18 months.
  • The Executive Board has been authorised, upon approval of the Supervisory Board, to have ForFarmers acquire (other than without consideration) shares in its own share capital (irrespective of the type) up to a maximum of 10% of the issued share capital of ForFarmers (determined at the time of the General Meeting).
    This authorization to acquire own shares enables the Executive Board to (a) execute share based (or depositary receipt-based) incentive schemes and employee participation plans and to (b) resume  the share buy-back programme in the maximum amount of €50 million (the market will be informed by means of a separate press release when the share buy-back programme will be resumed).

Decision on shares for share based (or depostary receipt-based) incentive shemes and the employee participation plans 2022
Taking into consideration the fact that the current share buy-back programme has temporarily been suspended, the Executive Board has decided, upon approval of the Supervisory Board and following the Annual General Meeting, to reserve from the already repurchased shares since december 2021, the required (depositary receipts of) shares for the share-based incentive scheme and employee participation plans 2022. This number of (depositary receipts of) shares is based on the total amount of the ‘on target’ distribution of long-term incentive schemes (expected to be approximately €1.4 million) in accordance with the remuneration policy which was adopted today, plus the expected number of shares required for the total amount of the 2022 employee participation plan registrations (for information: in 2021 shares were repurchased for approximately €1.0 million). The number of (depositary receipts of) shares that has been reserved for the emlpoyee participation plans and long-term incentive schemes (2022) will be repurchased and cancelled later.

This press release contains information which qualifies as inside information within the meaning of Article 7, paragraph 1 of the EU Market Abuse Regulation.

Note to the editor / For additional information:
Caroline Vogelzang, Director Investor Relations
T: 0031 573 288 194   M: 0031 6 10 94 91 61

Company profile
ForFarmers N.V. (‘ForFarmers’, Lochem, the Netherlands) is an internationally operating feed company that offers total feed solutions for conventional and organic livestock farming. ForFarmers gives its very best “For the Future of Farming”: for the continuity of farming and for a financially secure sector that will continue to serve society for generations to come in a sustainable way. By working side-by-side with farmers ForFarmers delivers real benefits: better returns, healthier livestock and greater efficiency. This is achieved by offering tailored and Total Feed solutions and a targeted approach with specialist and expert support. 
With sales of around 10 million tonnes of feed, ForFarmers is market leader in Europe. ForFarmers has approximately 2,500 employees and is active in the Netherlands, Belgium, Germany, Poland and the United Kingdom. In 2021, revenues amounted to approximately €2.7 billion. ForFarmers N.V. is listed at Euronext Amsterdam.  
ForFarmers N.V., Postbus 91, 7240 AB Lochem, T: +31 (0)573 28 88 00, F: +31 (0)573 28 88 99,,

This press release contains forward-looking statements, including those relating to ForFarmers legal obligations in terms of capital and liquidity positions in certain specified scenarios. In addition, forward-looking statements, without limitation, may include such phrases as “intends to”, "expects“, “takes into account”, "is aimed at“, ''plans to”, "estimated" and words with a similar meaning. These statements pertain to or may affect matters in the future, such as ForFarmers future financial results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties, which may mean that there could be material differences between actual results and performance and expected future results or performances that are implicitly or explicitly included in the forward-looking statements. Factors that may result in variations on the current expectations or may contribute to the same include but are not limited to: developments in legislation, technology, jurisprudence and regulations, share price fluctuations, legal procedures, investigations by regulatory bodies, the competitive landscape and general economic conditions. These and other factors, risks and uncertainties that may affect any forward-looking statements or the actual results of ForFarmers, are discussed in the last published annual report. The forward-looking statements in this press release are only statements as of the date of this document and ForFarmers accepts no obligation or responsibility with respect to any changes made to the forward-looking statements contained in this document, regardless of whether these pertain to new information, future events or otherwise, unless ForFarmers is legally obliged to do so.

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Ted Elvhage, Board member in Fingerprint Cards AB (publ), has sold shares due to private financial commitments19.5.2022 14:14:57 CEST | Press release

Ted Elvhage, Board member in Fingerprint Cards AB, has sold 975,000 shares in Fingerprints. “The reason for my sale of shares is private financial commitments. I have an unchanged strong belief in the company's future and plan to invest in Fingerprints again as soon as it is possible for me to do so,” comments Ted Elvhage. Link to PDMR transactions register. For further information, please contact: Investor Relations: +46(0)10-172 00 10, Press: +46(0)10-172 00 20, About Fingerprints Fingerprint Cards AB (Fingerprints) – the world’s leading biometrics company, with its roots in Sweden. We believe in a secure and seamless universe, where you are the key to everything. Our solutions are found in hundreds of millions of devices and applications, and are used billions of times every day, providing safe and convenient identification and authentication with a human touch. For more information visit our website, read our blog, and follow us on

GOGL – Q1 2022 Presentation19.5.2022 13:59:16 CEST | Press release

Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2022 results for today’s webcast / conference call at 15:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: Attend by Conference Call: Applicable dial-in telephone numbers are as follows: International Dial-In: +44 (0) 2071 92 8338 United Kingdom Toll Free: 08002796619 Norway Toll Free: 800 56 865 US Toll-Free: +1 877 870 9135 The presentation material which will be used in the teleconference/webcast can be downloaded on and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Golden Ocean Q1 2022 - Presentation

Vow ASA: Minutes of Annual General Meeting19.5.2022 12:40:04 CEST | Press release

The annual general meeting of Vow ASA was held today on 19 May 2022 at the company's premises at Lysaker Torg 12, 1366 Lysaker, Norway. All matters on the agenda were approved, cf. the notice of the Annual General Meeting that was published on 28 April 2022. The complete minutes are attached to this release. For further information, please contact: Erik Magelssen, CFO, Vow ASA Tel: +47 928 88 728 Email: About Vow Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company’s world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries. Cruise ships on every ocean have Vow technology inside which processes waste and purifies wastewater. Fish farmers are adopting similar solutions, and public utilities and industries use our solutions for sludge processing, waste management and biogas production on land. With advanced technologies and solution

Bavarian Nordic modtager vaccineordre fra europæisk land efter bekræftede tilfælde af abekopper19.5.2022 11:46:42 CEST | pressemeddelelse

KØBENHAVN, Danmark, 19. maj 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en kontrakt med et unavngivet europæisk land vedrørende levering af koppevaccinen IMVANEX® i forbindelse med nye tilfælde af abekopper, der er identificeret i løbet af maj 2022. Det første europæiske tilfælde blev bekræftet den 7. maj 2022 hos en person, der vendte hjem fra en rejse til Nigeria, hvor abekopper er naturligt forekommende. Efterfølgende er der bekræftet mere end 20 tilfælde i England, Portugal og Spanien, og flere formodede tilfælde er ved at blive undersøgt. De fleste infektioner lader til at være sket lokalt i de tre lande. I USA er der bekræftet et enkelt tilfælde hos en rejsende fra Canada, hvor der endnu ikke foreligger bekræftede tilfælde, men adskillige formodede tilfælde er ved at blive undersøgt. Bavarian Nordics koppevaccine er godkendt i USA under navnet JYNNEOS® og i Canada under navnet IMVAMUNE®. I begge lande er godkendelsen udvidet til at omfatte abek

Bavarian Nordic Secures Vaccine Order from European Country After Confirmed Monkeypox Cases19.5.2022 11:46:42 CEST | Press release

COPENHAGEN, Denmark, May 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022. The first European case was confirmed on May 7, 2022, in an individual who returned from a travel to Nigeria, where monkeypox is endemic. Subsequently, more than 20 cases have been confirmed across England, Portugal and Spain with additional suspected cases currently being investigated. Evidence points to that most of the infections have been acquired locally in these countries. In the US, a single case has been confirmed in a traveler from Canada, where no cases are yet confirmed, but several remain under investigation. Bavarian Nordic’s smallpox vaccine is approved in the U.S. as JYNNEOS® and in Canada as IMVAMUNE®, both places with the approval extended to cover the monkeypox indication. The vaccine is approved in Europe a